| Literature DB >> 18436539 |
Paul A Fowler1, Natalie J Dorà, Helen McFerran, Maria R Amezaga, David W Miller, Richard G Lea, Phillip Cash, Alan S McNeilly, Neil P Evans, Corinne Cotinot, Richard M Sharpe, Stewart M Rhind.
Abstract
Epidemiological studies of the impact of environmental chemicals on reproductive health demonstrate consequences of exposure but establishing causative links requires animal models using 'real life' in utero exposures. We aimed to determine whether prolonged, low-dose, exposure of pregnant sheep to a mixture of environmental chemicals affects fetal ovarian development. Exposure of treated ewes (n = 7) to pollutants was maximized by surface application of processed sewage sludge to pasture. Control ewes (n = 10) were reared on pasture treated with inorganic fertilizer. Ovaries and blood were collected from fetuses (n = 15 control and n = 8 treated) on Day 110 of gestation for investigation of fetal endocrinology, ovarian follicle/oocyte numbers and ovarian proteome. Treated fetuses were 14% lighter than controls but fetal ovary weights were unchanged. Prolactin (48% lower) was the only measured hormone significantly affected by treatment. Treatment reduced numbers of growth differentiation factor (GDF9) and induced myeloid leukaemia cell differentiation protein (MCL1) positive oocytes by 25-26% and increased pro-apoptotic BAX by 65% and 42% of protein spots in the treated ovarian proteome were differently expressed compared with controls. Nineteen spots were identified and included proteins involved in gene expression/transcription, protein synthesis, phosphorylation and receptor activity. Fetal exposure to environmental chemicals, via the mother, significantly perturbs fetal ovarian development. If such effects are replicated in humans, premature menopause could be an outcome.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18436539 PMCID: PMC2408934 DOI: 10.1093/molehr/gan020
Source DB: PubMed Journal: Mol Hum Reprod ISSN: 1360-9947 Impact factor: 4.025
Effects of sewage sludge on morphological and endocrine characteristics of Day 110 fetal ewes.
| Characteristic | Control | Sludge-exposed | Fold-change following sludge-exposure | ANOVA |
|---|---|---|---|---|
| Body weight (g) | 1593 ± 67 | 1365 ± 67 | −1.17 | |
| Ovary weight (mg) | 29.4 ± 2.1 | 31.0 ± 4.2 | +1.05 | NS |
| FSH (ng/ml) | 2.1 ± 0.3 | 1.4 ± 0.2 | −1.50 | NS |
| Estradiol (pmol/l) | 128 ± 54 | 100 ± 27 | −1.28 | NS |
| PRL (ng/ml) | 3.7 ± 0.7 | 1.9 ± 0.3 | −1.95 |
Lack of statistical significance (NS) is indicated where P > 0.05.
Figure 1:Effect of sewage sludge exposure on fetal ovarian morphology.
Immunolocalization of (a) MCL1, (b) GDF9 and (c) phosphorylated histone H3 expression in representative Day 110 fetal ovary sections. In (a) and (b), the arrow highlights immunopositive oocytes, whereas in (c), the arrow shows a histone pH3 positive granulosa cell. GDF9 and MCL1 immunopositive oocytes were present in all classes of follicles observed. Quantification (n = 15 control versus 8 treated ovaries) of the MCL1 immunohistochemistry is shown in (d) demonstrating the significant decrease in oocyte density in sewage sludge-exposed fetuses and (e) demonstrating the small but significant increase in the proportion of more advanced follicles in sewage sludge-exposed fetuses. Since the findings were similar between H&E staining and MCL1 and GDF9 positive oocytes, only the MCL1 data are shown to illustrate these results.
Figure 2:Quantification of levels of Day 110 fetal ovarian proteins (n = 15 control versus 8 treated ovaries) involved in (a) pro-apoptosis, BAX, (b) anti-apoptosis, BCL2, (c) developmental cell signalling, stem cell factor (SCF), (d) steroidogenesis, CYP17 and (e and f) oxidative stress response, manganese superoxide dismutase (SOD2).
P-values denote significant differences between control and sewage sludge-exposed fetuses and the load control was β-actin at 42 kDa.
Positively identified proteins showing differential expression between ovaries at GD110 from 15 control fetuses with 8 fetuses exposed to sewage sludge in utero.
| Spot # | Protein name | Protein function and | MW (kDa) | pI | MOWSE score | Accession number (NCBI) | Fold change ( |
|---|---|---|---|---|---|---|---|
| 1 | Gelsolin [actin depolymerising factor (ADF), brevin] | Promotes nucleation and severs formed filaments. Expression lost in ovarian carcinoma. | 80.9 | 5.58 | 429 | 2833344 | −2.8 ( |
| 2 | Vinculin | Involved in cell adhesion and focal complex assembly with role in actin microfilament attachment to plasma membranes. | 117.2 | 5.83 | 1050 | 4507877 | −3.4 ( |
| 9 | Tubulin α-chain (alpha-tubulin 1) | Major constituent of microtubules, binds two GTP molecules. | 50.6 | 4.97 | 383 | 3502919 | +3.1 ( |
| 5 | Serum albumin precursor | Secreted protein, typically into plasma, binding molecule, regulates colloidal osmotic pressure | 71.1 | 5.82 | 251 | 162648 | −5.2 ( |
| 10 | 97 | +3.0 ( | |||||
| 12 | 189 | Absent | |||||
| 8 | Albumin precursor | 71.1 | 5.80 | 483 | 1387 | +3.5 ( | |
| 16 | 646 | Unique | |||||
| 14 | Serotransferrin precursor (transferrin, siderophilin) | Iron-binding transport protein and stimulation of cell proliferation | 79.9 | 6.75 | 243 | 29135265 | −3.1 ( |
| 3 | DNA-binding pur alpha | Interacts with RNA and DNA and recruits regulatory proteins to specific nucleic acid sequences, stimulating transcription. | 34.8 | 5.88 | 61 | 9652255 | −5.0 ( |
| 7 | Heterogeneous nuclear ribonucleoprotein K (HNRPK) | Binds RNA, interacts with pur alpha to mediate repression of CD43 promoter. | 51.3 | 5.14 | 598 | 74354615 | +3.1 ( |
| 11 | Heterogeneous nuclear ribonucleoprotein H (HNRNPH) | Part of complex providing substrates for processing of pre-mRNA. | 49.5 | 5.89 | 475 | 10946928 | Absent |
| 4 | Endoplasmic reticulum protein ERp29 (ERp31 or ERp28) | Molecular chaperone, participates in the folding of secretory proteins in endoplasmic reticulum. | 28.9 | 5.63 | 270 | 109658363 | −3.2 ( |
| 6 | Calmodulin (CaM) | Mediates the control of enzymes and proteins (e.g. protein kinases and phosphatases) by Ca, role in calcium signalling. | 16.8 | 4.09 | 224 | 115509 | −3.1 ( |
| 17 | Tu translation elongation factor (EF-Tu) | Role in protein synthesis, promoting GTP-dependent binding of tRNA to ribosomes. | 49.7 | 6.72 | 235 | 111304949 | Unique |
| 18 | Tumor rejection antigen 1 (GP96) (HSP90 family) | Molecular chaperone during processing, folding and transport of secreted proteins in the endoplasmic reticulum. | 92.7 | 4.76 | 727 | 27807263 | Unique |
| 13 | Guanine nucleotide-binding protein G, beta 1 (transductin beta 1 chain) | Part of G-protein heterotrimer, transduces transmembrane signalling systems. | 38.2 | 5.60 | 384 | 6680045 | Absent |
| 15 | Protein phosphatase 1D | Required for relief of p53-dependent checkpoint mediated cell cycle, negatively regulates cell proliferation. | 38.0 | 5.84 | 351 | 227436 | +4.6 ( |
| 19 | S100 calcium-binding protein A11 (similar to) | Proposed function is calcium-ion binding and signal transduction, negative regulation of cell proliferation. | 11.5 | 6.72 | 202 | 29135265 | Unique |
Figure 3:2-DE gel electrophoresis based proteomic analysis of Day 110 fetal ovaries (n = 15 control versus 8 treated ovaries) pooled into treated and control groups.
(a) Representative 2-DE 7 cm gel using a 4–7 pH gradient. The numbered arrows show the location of the 19 protein spots identified in Table II. Zoom boxes demonstrating representative protein spots showing (b) down-regulation and (c) up-regulation in fetuses exposed to sewage sludge. The histograms are based on averaged (n = 4 gels/group) spot volume (normalized relative to total spot volumes separately for each gel). Significant differences are based on ANOVA following log-transformation of spot volumes.
Figure 4:Biological processes network of some of the differentially expressed proteins from the treated ovaries, demonstrating key interactions between CALM1 and HNRPH in regulating (a) translation and antagonism between SOD2 and BAX in (b) DNA fragmentation during apoptosis.
Output from Pathway Architect.
Figure 5:Biological interactions network of some of the differentially expressed proteins from the treated ovaries.
CALM1 sits central within the network, interacting with most of the differentially regulated proteins via one or two steps. Ovals with a green background denote small molecules. Output from Pathway Architect software (Stratagene Europe, Amsterdam, the Netherlands).